MOSCHETTA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 15.037
AS - Asia 5.751
EU - Europa 5.180
SA - Sud America 1.672
Continente sconosciuto - Info sul continente non disponibili 833
AF - Africa 331
OC - Oceania 11
Totale 28.815
Nazione #
US - Stati Uniti d'America 14.765
SG - Singapore 2.322
IT - Italia 1.991
BR - Brasile 1.337
CN - Cina 1.283
HK - Hong Kong 710
SE - Svezia 634
RU - Federazione Russa 568
DE - Germania 473
VN - Vietnam 424
FI - Finlandia 319
FR - Francia 309
GB - Regno Unito 302
UA - Ucraina 220
BD - Bangladesh 219
IN - India 179
CI - Costa d'Avorio 142
CA - Canada 126
ID - Indonesia 113
AR - Argentina 107
IQ - Iraq 80
NL - Olanda 79
MX - Messico 72
TR - Turchia 69
ZA - Sudafrica 63
CO - Colombia 53
EC - Ecuador 50
PK - Pakistan 50
JP - Giappone 45
VE - Venezuela 45
SA - Arabia Saudita 43
PL - Polonia 42
IE - Irlanda 39
BE - Belgio 37
AT - Austria 36
ES - Italia 36
UZ - Uzbekistan 30
PH - Filippine 27
MA - Marocco 26
PY - Paraguay 24
CL - Cile 21
MY - Malesia 21
PE - Perù 19
KE - Kenya 18
TN - Tunisia 18
LT - Lituania 17
CZ - Repubblica Ceca 16
EG - Egitto 15
KR - Corea 15
JM - Giamaica 14
JO - Giordania 14
IL - Israele 13
AU - Australia 11
DZ - Algeria 11
NP - Nepal 10
AL - Albania 9
ET - Etiopia 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
PS - Palestinian Territory 8
SV - El Salvador 8
TT - Trinidad e Tobago 8
BO - Bolivia 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
HN - Honduras 7
KZ - Kazakistan 7
LB - Libano 7
OM - Oman 7
PT - Portogallo 7
UY - Uruguay 7
NI - Nicaragua 6
PA - Panama 6
AO - Angola 5
AZ - Azerbaigian 5
BH - Bahrain 5
GR - Grecia 5
GT - Guatemala 5
IR - Iran 5
KW - Kuwait 4
RO - Romania 4
RS - Serbia 4
TH - Thailandia 4
BY - Bielorussia 3
GE - Georgia 3
HU - Ungheria 3
KG - Kirghizistan 3
PR - Porto Rico 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
BJ - Benin 2
BN - Brunei Darussalam 2
CV - Capo Verde 2
EU - Europa 2
HR - Croazia 2
IM - Isola di Man 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
Totale 27.943
Città #
Fairfield 1.654
Ashburn 1.465
Singapore 1.219
Woodbridge 1.136
San Jose 846
Houston 824
Chandler 733
Hong Kong 700
Seattle 614
Cambridge 603
Wilmington 536
Milan 532
Nyköping 493
Jacksonville 480
Ann Arbor 464
Beijing 385
Council Bluffs 332
Bari 277
New York 244
Los Angeles 204
Lauterbourg 202
Lawrence 190
Roxbury 188
Rome 185
Nanjing 183
Dallas 153
Helsinki 146
Abidjan 142
Santa Clara 132
Dearborn 126
Ho Chi Minh City 125
Boardman 114
Des Moines 114
Columbus 109
Munich 101
Buffalo 100
Inglewood 98
Chicago 92
Hanoi 92
Brooklyn 91
São Paulo 91
Princeton 89
Jakarta 79
San Diego 77
London 66
Falkenstein 58
Shenyang 49
Montreal 44
Hebei 43
Nuremberg 42
Phoenix 42
Figino 41
Frankfurt am Main 41
Atlanta 40
Rio de Janeiro 40
Dublin 38
Moscow 38
Naples 35
Orem 35
Tokyo 35
Brussels 34
Dong Ket 34
Turku 34
Jiaxing 33
San Francisco 33
Turin 33
Denver 32
Nanchang 32
Warsaw 32
Belo Horizonte 30
Guangzhou 30
San Giovanni Teatino 30
Chennai 29
Johannesburg 28
Toronto 28
Salt Lake City 26
Tashkent 25
Baghdad 24
Cressa 24
Curitiba 24
Paris 24
Tianjin 24
Dhaka 23
Istanbul 23
Porto Alegre 23
Brasília 22
Da Nang 22
Poplar 22
Mexico City 21
Boston 20
Changsha 20
Hefei 19
Indianapolis 19
Lahore 18
Manchester 18
The Dalles 18
Haiphong 17
Nairobi 17
Pescara 17
Redwood City 17
Totale 18.446
Nome #
Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study 469
Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators 265
Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4-/- Mice 254
Gut Microbiota Modulation and Its Implications on Neuropathic Pain: A Comprehensive Literature Review 233
TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours 205
PGC-1α induced browning promotes involution and inhibits lactation in mammary glands 202
Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy. 198
Adenomatous polyposis coli (APC)-induced apoptosis of HT29 colorectal cancer cells depends on mitochondrial oxidative metabolism 197
Hepatic microRNA Expression by PGC-1α and PGC-1β in the Mouse 196
Genes and miRNA expression signatures in peripheral blood mononuclear cells in healthy subjects and patients with metabolic syndrome after acute intake of extra virgin olive oil 193
Role of oleic acid in the gut-liver axis: From diet to the regulation of its synthesis via Stearoyl-CoA desaturase 1 (SCD1) 193
Basolateral Ca2+-dependent K+-channels play a key role in Cl- secretion induced by taurodeoxycholate from colon mucosa 192
Integrative miRNA and Whole-Genome Analyses of Epicardial Adipose Tissue in Patients with Coronary Atherosclerosis 191
Deletion of Stearoyl-CoA Desaturase-1 From the Intestinal Epithelium Promotes Inflammation and Tumorigenesis, Reversed by Dietary Oleate 190
Extra virgin olive oil: Lesson from nutrigenomics 187
Sindrome metabolica e lavoro 186
The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19 184
Extra-virgin olive oil from Apulian cultivars and intestinal inflammation 184
Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations 182
Hepatic peroxisome proliferator‐activated receptor γ coactivator 1β drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice 180
Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β 179
Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinoma. 175
Regular extra-virgin olive oil intake independently associates with lower abdominal obesity 174
Atherosclerosis: lessons from LXR and the intestine. 173
Activation of LXRs prevents bile acid toxicity and cholestasis in female mice 168
Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes 167
Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in mice 164
Nuclear receptors expression chart in peripheral blood mononuclear cells identifies patients with Metabolic Syndrome. 162
A phylogenetic survey of biliary lipids in vertebrates 160
The European accreditation of Istituto Tumori Giovanni Paolo II of Bari 160
Nuclear receptors in regenerating liver and hepatocellular carcinoma 159
A Novel Protective Role for FXR against Inflammasome Activation and Endotoxemia 157
Bile acids lower triglyceride levels via a pathway involving FXR, SHP and SREBP1c 155
The Intestinal Nuclear Receptor Signature With Epithelial Localization Patterns and Expression Modulation in Tumors 152
Relationship Between Oral Lesions and Severe SARS-CoV-2 Infection in Intensive Care Unit Patients 151
let-7e downregulation characterizes early phase colonic adenoma in APCMin/+ mice and human FAP subjects 150
Hepatic-specific PPARa-FGF21 action in NAFLD 149
Pathophysiology of cholesterol gallstone disease 148
Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease. 147
PGC-1β Induces Susceptibility To Acetaminophen-Driven Acute Liver Failure 147
Effect of hydrosoluble vitamin E on erythrocyte membrane lipid composition in patients with advanced cirrhosis: An open-label pilot trial. 146
FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption 145
A translational view on the biliary lipid secretory network 145
Mitochondrial function - gatekeeper of intestinal epithelial cell homeostasis 145
Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis 145
Casting a shadow on liver X receptor-mediated atheroprotection: is LXRβ to blame? 144
Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2 144
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling 143
Intestinal FXR Activation via Transgenic Chimera or Chemical Agonism Prevents Colitis-Associated and Genetically-Induced Colon Cancer 142
The "hemolysis model" for the study of cyto-toxicity and cyto-protection by bile salts and phospholipids 142
Intracoronary monocyte expression pattern and HDL subfractions after non-ST elevation myocardial infarction 142
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23 141
The emerging discipline of precision cooking: a suitable tool for the precision nutrition 140
Parallel intestinal and liver injury during early cholestasis in the rat: modulation by bile salts and antioxidants 139
Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer 139
The FXR-FGF19 Gut-Liver Axis as a Novel "hepatostat" 138
LXRs, SHP, and FXR in Prostate Cancer: Enemies or Ménage à Quatre With AR? 138
Aminotransferase activity in morbid and uncomplicated obesity: Predictive role of fasting insulin 138
Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. 138
AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects 138
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease 137
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 134
Primary sclerosing cholangitis: updates in diagnosis and therapy. 133
Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio 133
Intestinal ecology in the metabolic syndrome 133
Effects of hydrophobic and hydrophilic bile salt mixtures on cholesterol crystallization in model biles 132
Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes 132
LA SINDROME METABOLICA NEGLI ADDETTI ALLA PESCA MARITTIMA 132
Lipid metabolism in colon cancer: Role of Liver X Receptor (LXR) and Stearoyl-CoA Desaturase 1 (SCD1) 131
Fasting hyperglycaemia and fatty liver drive colorectal cancer: a retrospective analysis in 1145 patients 130
Pathways of cholesterol crystallization in model bile and native bile 130
Liver X Receptors Inhibit Proliferation of Human Colorectal Cancer Cells and Growth of Intestinal Tumors in Mice 130
Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome 129
Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis 129
Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis. 129
Water handling and aquaporins in bile formation: recent advances and research trends 129
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor 129
Another one bites the gut: Nuclear receptor lrh-1 in intestinal regeneration and cancer 129
Adhesion of platelets to colon cancer cells is necessary to promote tumor development in xenograft, genetic and inflammation models 129
Extra virgin olive oil extracts modulate the inflammatory ability of murine dendritic cells based on their polyphenols pattern: Correlation between chemical composition and biological function 129
Enterocyte superoxide dismutase 2 deletion drives obesity 129
Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD) 128
Asymmetric distribution of phosphatidylcholine and sphyngomyelin between micellar and vesicular phases: potential implication for canalicular bile formation 127
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease 127
Tissue-specific actions of FXR in metabolism and cancer. 126
Identification of miR-9-5p as direct regulator of ABCA1 and HDL-driven reverse cholesterol transport in circulating CD14+ cells of patients with metabolic syndrome 126
Welcoming Foxa2 in the bile acid entourage 126
Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1 126
Preface: a special issue on nuclear receptors with a special view on the molecular basis of disease. 125
Nuclear receptors, intestinal architecture and colon cancer: an intriguing link 125
Interleukins 1 beta and 6 induce functional alteration of rat colonic motility: an in vitro study 125
Nuclear receptors and cholesterol metabolism in the intestine 125
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis 124
SEL1L, an UPR response protein, a potential marker of colonic cell transformation. 124
Microscopic esophagitis and Barrett in endoscopy-negative gastroesophageal reflux disease (GERD) 124
Bile acids and colon cancer: Is FXR the solution of the conundrum? 124
Bile acids and colon cancer: Solving the puzzle with nuclear receptors 123
Taurodeoxycholate-induced intestinal injury is modulated by oxidative stress-dependent pre-conditioning like mechanisms 122
Linking transcription to physiology in lipidomics 122
Intestinal nuclear receptors in HDL cholesterol metabolism. 122
Totale 15.429
Categoria #
all - tutte 118.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.981


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.259 0 0 31 65 59 191 51 90 113 125 236 298
2022/20232.116 331 224 138 158 223 304 17 256 342 22 51 50
2023/2024855 52 170 37 52 68 211 33 53 7 29 41 102
2024/20254.378 151 30 320 146 105 366 519 380 229 261 585 1.286
2025/20269.582 1.286 428 611 1.084 978 532 969 298 1.012 958 365 1.061
2026/20271.703 850 643 210 0 0 0 0 0 0 0 0 0
Totale 28.815